ایران دارو
دیران | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
-
Last Price: - 0.00
Close Price: 3,123
Balance Sheet
AGM
Interim
2026/05/20 Fiscal Year 2025/12/2112 Month | 2025/04/20 Fiscal Year 2024/12/2012 Month | 2024/04/17 Fiscal Year 2023/12/2112 Month | ||
|---|---|---|---|---|
Cash & Bank Balances | 91.729 Billion | 98.84 Billion | 267.107 Billion | |
Trade Receivables | 7.131 Trillion | 6.858 Trillion | 4.797 Trillion | |
Prepayments | 966.91 Billion | 428.012 Billion | 196.869 Billion | |
Raw Materials & Packaging Inventory | 1.652 Trillion | 1.125 Trillion | 1.065 Trillion | |
Work-in-Progress Inventory | 321.856 Billion | 111.131 Billion | 176.01 Billion | |
Finished Goods Inventory | 8.511 Billion | 28.657 Billion | 54.959 Billion | |
Spare Parts Inventory | 58.894 Billion | 47.124 Billion | 45.954 Billion | |
Goods in Transit | - | 15.719 Billion | 71.563 Billion | |
Our Goods on Consignment with Others | - | 9.316 Billion | - | |
Other Inventories | 95.799 Billion | 47.581 Billion | - | |
Inventories | 2.137 Trillion | 1.384 Trillion | 1.442 Trillion | |
Total Current Assets | 10.326 Trillion | 8.77 Trillion | 6.703 Trillion | |
Long-Term Investments | 2.512 Billion | 2.543 Billion | 527 Million | |
Long-Term Trade Receivables | 5.767 Billion | 2.884 Billion | 7.362 Billion | |
Intangible Assets | 86.048 Billion | 13.064 Billion | 13.093 Billion | |
Property, Plant & Equipment | 355.265 Billion | 246.7 Billion | 162.535 Billion | |
Net Fixed Assets | 355.265 Billion | 246.7 Billion | 162.535 Billion | |
Total Non-Current Assets | 449.592 Billion | 265.191 Billion | 183.517 Billion | |
Total Assets | 10.776 Trillion | 9.035 Trillion | 6.887 Trillion | |
Trade Payables | 3.267 Trillion | 1.867 Trillion | 892.625 Billion | |
Advances Received | 36.651 Billion | 115.046 Billion | 31.386 Billion | |
Income Tax Provision | 456.298 Billion | 288.147 Billion | 407.101 Billion | |
Proposed & Payable Dividends | 220.862 Billion | 763.554 Billion | 482.893 Billion | |
Current Borrowings | 2.377 Trillion | 2.131 Trillion | 2.63 Trillion | |
Total Current Liabilities | 6.358 Trillion | 5.164 Trillion | 4.444 Trillion | |
Long-Term Payables | 22.59 Billion | 57.506 Billion | 38.5 Billion | |
Long-Term Borrowings | 1.5 Trillion | 1.5 Trillion | - | |
Employee Termination Benefits Provision | 369.099 Billion | 215.839 Billion | 147.865 Billion | |
Total Non-Current Liabilities | 1.892 Trillion | 1.773 Trillion | 186.365 Billion | |
Total Liabilities | 8.249 Trillion | 6.938 Trillion | 4.63 Trillion | |
Capital | 1.78 Trillion | 1.33 Trillion | 880 Billion | |
Capital Raise in Progress | - | 429.021 Billion | 406.609 Billion | |
Retained Earnings | 644.503 Billion | 380.519 Billion | 1.024 Trillion | |
Legal Reserve | 107.049 Billion | 88.875 Billion | 88 Billion | |
Share Premium Reserve | -5.143 Billion | -131.46 Billion | -141.877 Billion | |
Other Reserves | 39 Million | 39 Million | 39 Million | |
Total Equity | 2.526 Trillion | 2.097 Trillion | 2.257 Trillion | |
Total Liabilities & Equity | 10.776 Trillion | 9.035 Trillion | 6.887 Trillion | |
Approved Capital | 1.78 Trillion | 1.33 Trillion | 880 Billion | |
Approved Capital Raise in Progress | - | 429.021 Billion | 406.609 Billion | |
Approved Retained Earnings | 591.103 Billion | 364.499 Billion | 289.106 Billion | |
Approved Legal Reserve | 107.049 Billion | 88.875 Billion | 88 Billion | |
Other Approved Reserves | 39 Million | 39 Million | 39 Million | |
Total Approved Equity (at AGM) | 2.478 Trillion | 2.212 Trillion | 1.664 Trillion | |
انبار ملزومات | - | - | 28.391 Billion |